Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Impaired Renal Function and Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04908436
What this trial is testing

Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureChronic Kidney Disease
Bayer 33
Early research (Phase 1)Study completedNCT03161015
What this trial is testing

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Global Blood Therapeutics 16
Early research (Phase 1)Study completedNCT03172884
What this trial is testing

Study of Copanlisib in Hepatic or Renal Impairment

Who this might be right for
Hepatic Insufficiency, Renal Insufficiency
Bayer 30
Early research (Phase 1)Ended earlyNCT00721422
What this trial is testing

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Who this might be right for
Renal InsufficiencyPharmacokinetics
Pfizer 16
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Early research (Phase 1)Study completedNCT05004311
What this trial is testing

The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics

Who this might be right for
HealthyRenal Impairment
Viatris Innovation GmbH 16
Early research (Phase 1)Study completedNCT02653014
What this trial is testing

Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
KBP Biosciences 26
Early research (Phase 1)Study completedNCT03310463
What this trial is testing

Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects

Who this might be right for
Acinetobacter Baumannii Infection
Entasis Therapeutics 34
Early research (Phase 1)Study completedNCT02807077
What this trial is testing

PK of Pacritinib in Patients With Mild, Moderate, Severe Renal Impairment and ESRD Compared to Healthy Subjects

Who this might be right for
Myelofibrosis
CTI BioPharma 40
Early research (Phase 1)WithdrawnNCT01468259
What this trial is testing

A Multi-Center, Open-Label Study

Who this might be right for
Renal DiseaseEnd Stage Renal Disease
Chelsea Therapeutics
Early research (Phase 1)Study completedNCT00805090
What this trial is testing

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Who this might be right for
Renal Insufficiency, ChronicHepatic InsufficiencyHealthy
Javelin Pharmaceuticals 37
Early research (Phase 1)Study completedNCT03506854
What this trial is testing

Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients

Who this might be right for
Renal Impairment
Akcea Therapeutics 16
Early research (Phase 1)Study completedNCT04935294
What this trial is testing

Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction

Who this might be right for
HealthyRenal Dysfunction
Alexion Pharmaceuticals, Inc. 16
Early research (Phase 1)Study completedNCT01833754
What this trial is testing

Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis

Who this might be right for
Osteoporosis
Amgen 24
Early research (Phase 1)Study completedNCT03235076
What this trial is testing

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
Bayer 36
Early research (Phase 1)Study completedNCT02340195
What this trial is testing

Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 16
Early research (Phase 1)Study completedNCT02007941
What this trial is testing

Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects

Who this might be right for
Renal ImpairmentHealthy
Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT00731523
What this trial is testing

Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.

Who this might be right for
Renal Insufficiency
Novartis 18
Early research (Phase 1)Study completedNCT01424176
What this trial is testing

Dexpramipexole Renal PK Study

Who this might be right for
Amyotrophic Lateral SclerosisRenal Insufficiency
Knopp Biosciences 36
Early research (Phase 1)Study completedNCT03836599
What this trial is testing

Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects

Who this might be right for
Chronic Kidney Disease
AstraZeneca 6
Next Page